Vicarious Surgical Inc RBOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RBOT is a good fit for your portfolio.
News
-
Vicarious Surgical Reports First Quarter 2024 Financial Results
-
Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024
-
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
-
Thinking about buying stock in On Holding, Genco Shipping & Trading, Rio Tinto, Vicarious Surgical, or Plug Power?
-
Vicarious Surgical to Participate in TD Cowen’s 44th Annual Healthcare Conference
-
Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Trading Information
- Previous Close Price
- $0.30
- Day Range
- $0.30–0.31
- 52-Week Range
- $0.20–2.46
- Bid/Ask
- $0.28 / $0.31
- Market Cap
- $45.70 Mil
- Volume/Avg
- 193,713 / 589,592
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 131
Comparables
Valuation
|
Metric
|
RBOT
|
MMSI
|
ZIMV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 25.15 | 9.69 |
Price/Book Value | 0.65 | 3.70 | 1.04 |
Price/Sales | — | 3.60 | 0.91 |
Price/Cash Flow | — | 20.23 | 12.28 |
Price/Earnings
RBOT
MMSI
ZIMV
Financial Strength
|
Metric
|
RBOT
|
MMSI
|
ZIMV
|
|---|---|---|---|
Quick Ratio | 16.57 | 4.22 | 0.84 |
Current Ratio | 17.16 | 6.03 | 2.78 |
Interest Coverage | −2,710.71 | 6.17 | −1.51 |
Quick Ratio
RBOT
MMSI
ZIMV
Profitability
|
Metric
|
RBOT
|
MMSI
|
ZIMV
|
|---|---|---|---|
Return on Assets (Normalized) | −49.29% | 9.17% | 14.12% |
Return on Equity (Normalized) | −63.37% | 15.14% | 31.63% |
Return on Invested Capital (Normalized) | −58.04% | 10.93% | 18.79% |
Return on Assets
RBOT
MMSI
ZIMV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Xjcdlqcs | Rlsmyg | $184.2 Bil | |
SYK
| Stryker Corp | Pcsdkbkhv | Lhwkm | $125.1 Bil | |
MDT
| Medtronic PLC | Dhkqnffqn | Hlxyf | $108.5 Bil | |
BSX
| Boston Scientific Corp | Ftmcbzgz | Kcrrdm | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Dtbrhwylm | Xqcmjn | $51.4 Bil | |
DXCM
| DexCom Inc | Lcncqxfy | Dwhl | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Crtdpslryt | Vgzdg | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Fpmwcztm | Lkvqhkv | $24.4 Bil | |
ALGN
| Align Technology Inc | Qlyvljm | Jljhmz | $21.7 Bil | |
PODD
| Insulet Corp | Gjnhjdzmmw | Drdtb | $12.2 Bil |